A. Dorst

919 total citations
10 papers, 658 citations indexed

About

A. Dorst is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, A. Dorst has authored 10 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Orthopedics and Sports Medicine, 9 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in A. Dorst's work include Bone health and osteoporosis research (10 papers), Bone health and treatments (9 papers) and Bone and Joint Diseases (6 papers). A. Dorst is often cited by papers focused on Bone health and osteoporosis research (10 papers), Bone health and treatments (9 papers) and Bone and Joint Diseases (6 papers). A. Dorst collaborates with scholars based in Germany, Italy and Switzerland. A. Dorst's co-authors include J. D. Ringe, H. Faber, P. Farahmand, Lucio C. Rovati, I Setnikar, Volker W. Rahlfs, E. Schacht and J. D. Ringe and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Osteoporosis International and Rheumatology International.

In The Last Decade

A. Dorst

9 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Dorst Germany	8	588	420	185	145	102	10	658
H. Faber Germany	9	545 0.9×	398 0.9×	171 0.9×	148 1.0×	99 1.0×	11	644
P. Chen United States	8	493 0.8×	259 0.6×	155 0.8×	188 1.3×	70 0.7×	8	646
Dietrich Wenderoth United Kingdom	9	825 1.4×	649 1.5×	373 2.0×	158 1.1×	85 0.8×	13	948
John Graham Australia	5	586 1.0×	449 1.1×	163 0.9×	194 1.3×	76 0.7×	5	748
Kurt Weber Austria	5	607 1.0×	446 1.1×	162 0.9×	205 1.4×	129 1.3×	8	809
Inge I. de Liefde Netherlands	8	346 0.6×	198 0.5×	185 1.0×	210 1.4×	38 0.4×	11	607
R. Chapurlat France	8	366 0.6×	139 0.3×	123 0.7×	146 1.0×	70 0.7×	23	531
Quanle Qi United States	7	239 0.4×	257 0.6×	87 0.5×	50 0.3×	124 1.2×	7	574
Jessica Fleischer United States	9	204 0.3×	119 0.3×	87 0.5×	246 1.7×	112 1.1×	11	553
TM Murray Canada	8	213 0.4×	100 0.2×	111 0.6×	62 0.4×	69 0.7×	10	389

Countries citing papers authored by A. Dorst

Since Specialization

Citations

This map shows the geographic impact of A. Dorst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Dorst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Dorst more than expected).

Fields of papers citing papers by A. Dorst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Dorst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Dorst. The network helps show where A. Dorst may publish in the future.

Co-authorship network of co-authors of A. Dorst

This figure shows the co-authorship network connecting the top 25 collaborators of A. Dorst. A scholar is included among the top collaborators of A. Dorst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Dorst. A. Dorst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Ringe, J. D. & A. Dorst. (2008). Osteoporose bei Männern: Pathogenese und klinische Einteilung bei 254 Fällen. DMW - Deutsche Medizinische Wochenschrift. 119(27). 943–947.

Ringe, J. D., P. Farahmand, H. Faber, & A. Dorst. (2008). Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study. Rheumatology International. 29(3). 311–315. 67 indexed citations

Ringe, J. D., et al.. (2005). Efficacy of etidronate and sequential monofluorophosphate in severe postmenopausal osteoporosis: a pilot study. Rheumatology International. 25(4). 296–300. 6 indexed citations

Ringe, J. D., H. Faber, P. Farahmand, & A. Dorst. (2005). Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study. Rheumatology International. 26(5). 427–431. 120 indexed citations

Ringe, J. D., A. Dorst, & H. Faber. (2005). Effective and rapid treatment of painful localized transient osteoporosis (bone marrow edema) with intravenous ibandronate. Osteoporosis International. 16(12). 2063–2068. 68 indexed citations

Schacht, E., J. D. Ringe, A. Dorst, Volker W. Rahlfs, & H. Faber. (2004). Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis. Rheumatology International. 24(2). 63–70. 35 indexed citations

Ringe, J. D., et al.. (2004). Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study. Rheumatology International. 24(2). 110–113. 76 indexed citations

Ringe, J. D., et al.. (2003). Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study. Osteoporosis International. 14(10). 801–807. 131 indexed citations

Ringe, J. D., H. Faber, & A. Dorst. (2001). Alendronate Treatment of Established Primary Osteoporosis in Men: Results of a 2-Year Prospective Study. The Journal of Clinical Endocrinology & Metabolism. 86(11). 5252–5255. 94 indexed citations

10.

Ringe, J. D., et al.. (1998). Avoidance of Vertebral Fractures in Men with Idiopathic Osteoporosis by a Three Year Therapy with Calcium and Low-Dose Intermittent Monofluorophosphate. Osteoporosis International. 8(1). 47–52. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact